Mkts

Dianthus Therapeutics, Inc.

NASDAQ: DNTH
$89.30+0.49 (+0.55%)
As of Nov 11, 4:00 PM ET

Key statistics

Day range
87.9790.45
52-week range
34.29117.88
Today
Open89.05
Previous close89.30
Volume—
Valuation
Market cap4.98B
P/E ratio—
EPS (TTM)-4.15
Income & risk
Dividend / yield—
Beta2.06
Avg volume856.6K
Discussion

DNTH News

Stories mentioning DNTH from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue284.00396.00193.001,1631,3262,1721,863
Cost of Goods Sold
Gross Profit0.00
Operating Expenses
Research & Development34,52859,89532,48926,25127,00326,41325,54418,070
Sales General & Admin
Total Operating Expenses46,99669,82540,68435,12034,34033,24232,07224,067
Operating Income (Loss)(46,533)(69,541)(40,288)(34,927)(33,177)(31,916)(29,900)(22,204)
Interest Income5,0474,4121,3472,3051,8921,2532,1044,286
Interest Expense
Other Expense(249.00)(409.00)(360.00)(107.00)(98.00)(382.00)22.00(80.00)
Pretax Income
Tax Provision
Net Income (Loss)(40,834)(64,432)(36,765)(31,629)(29,511)(28,440)(25,174)(17,607)
Earnings Per Share (Basic)(0.85)(1.67)(0.97)(0.88)(0.82)(0.85)(0.74)(0.51)
Earnings Per Share (Diluted)(0.85)(1.67)(0.97)(0.88)(0.82)(0.85)(0.74)(0.51)
Weighted Average Shares Outstanding (Basic)48,03338,61837,79435,82235,79133,31434,23734,227
Weighted Average Shares Outstanding (Diluted)48,03338,61837,79435,82235,79133,31434,23734,227

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About DNTH

Dianthus Therapeutics, Inc. (NASDAQ: DNTH) is a stock listed on the Nasdaq Stock Market under the ticker symbol DNTH. It last traded at $89.30 (Nov 11, 2026, 4:00 PM ET), up 0.6% on the day. That gives Dianthus Therapeutics a market capitalisation of $5.0B.

Over the past 52 weeks DNTH has traded between $34.29 and $117.88.

For the quarter ended Mar 31, 2026 it reported a net loss of $40.8M.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026—-$40.8M—
Dec 31, 2025$284.0K-$64.4M-22687.3%
Sep 30, 2025$396.0K-$36.8M-9284.1%
Jun 30, 2025$193.0K-$31.6M-16388.1%

From Dianthus Therapeutics’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…